Drug Shortage Report for ACT OLANZAPINE ODT
Report ID | 93156 |
Drug Identification Number | 02327562 |
Brand name | ACT OLANZAPINE ODT |
Common or Proper name | OLANZAPINE ODT |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OLANZAPINE |
Strength(s) | 5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-09-05 |
Estimated end date | Unknown |
Actual end date | 2019-10-25 |
Shortage status | Resolved |
Updated date | 2019-10-26 |
Company comments | Item is discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-10-26 | English | Compare |
v5 | 2019-10-25 | French | Compare |
v4 | 2019-10-25 | English | Compare |
v3 | 2019-09-06 | English | Compare |
v2 | 2019-09-05 | French | Compare |
v1 | 2019-09-05 | English | Compare |
Showing 1 to 6 of 6